Date published: 2026-4-29

1-800-457-3801

SCBT Portrait Logo
Seach Input

FAM107B Inhibitors

FAM107B inhibitors belong to a distinct class of chemical compounds designed to modulate the activity of the FAM107B protein. FAM107B, also known as C9orf92 or FOAP-11, is a relatively understudied protein that has recently garnered attention for its potential implications in various cellular processes. This class of inhibitors aims to selectively target and regulate the function of FAM107B, which is thought to play a role in cellular proliferation, migration, and other fundamental biological activities. The inhibitors are designed to interact with specific binding sites on the FAM107B protein, altering its conformation or blocking its active sites to regulate downstream signaling pathways. Structurally, FAM107B inhibitors encompass a diverse array of chemical entities, ranging from small organic molecules to more complex compounds. Researchers employ a variety of computational and experimental techniques to design and optimize these inhibitors, ensuring specificity and efficacy in modulating FAM107B activity. The development of FAM107B inhibitors is an active area of research within the field of chemical biology, as scientists seek to unravel the intricacies of FAM107B's cellular functions and explore potential applications in various physiological contexts.

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$153.00
$396.00
113
(4)

Staurosporine is a potent kinase inhibitor that can inhibit a wide range of protein kinases. If FAM107B activity is regulated by phosphorylation, staurosporine may alter its activity.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002 is a PI3K inhibitor, which could affect pathways that regulate cell survival and apoptosis. If FAM107B is part of such pathways, LY294002 may indirectly influence its function.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$64.00
$246.00
136
(2)

U0126 is a MEK inhibitor, which can disrupt the MAPK/ERK pathway. If FAM107B is involved in this pathway, U0126 may indirectly affect its activity.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

SB203580 is a p38 MAPK inhibitor, and if FAM107B is implicated in stress response pathways, this compound may modulate its activity indirectly.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

PD98059 is another MEK inhibitor that can interfere with the MAPK/ERK pathway, potentially influencing FAM107B activity if connected.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Rapamycin inhibits mTOR, which is a central regulator of cell growth and proliferation. If FAM107B is linked to these processes, rapamycin may indirectly affect its function.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Wortmannin is a potent inhibitor of PI3K, also affecting pathways of cell survival and growth. It could affect FAM107B if it is part of or regulated by these pathways.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

SP600125 is an inhibitor of JNK, and by inhibiting this kinase, it may influence FAM107B's role in apoptosis or cellular stress if it is involved.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

Bortezomib inhibits proteasomal degradation. If FAM107B is regulated by proteasomal degradation, bortezomib could indirectly influence its levels and function.

Thapsigargin

67526-95-8sc-24017
sc-24017A
1 mg
5 mg
$136.00
$446.00
114
(2)

Thapsigargin is a SERCA pump inhibitor, elevating cytosolic calcium levels and potentially affecting proteins like FAM107B if they are calcium-sensitive.